ALVR - Allovir Inc - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-67.15M

Cash

246.5M

Avg Qtr Burn

-31.48M

Short % of Float

23.24%

Insider Ownership

49.35%

Institutional Own.

35.14%

Qtr Updated

06/30/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Posoleucel Details Human herpesvirus 6, Epstein-Barr virus, Adenovirus, BK virus, Cytomegalovirus	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Posoleucel Details Virus-associated hemorrhagic cystitis , Adenovirus	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Posoleucel Details BK virus, Kidney transplantation	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ALVR106 Details Parainfluenza virus, Human metapneumovirus, Respiratory syncytial virus, Influenza	Phase 1/2 Interim update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ALVR109 Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.